Call for Abstract
Scientific Program
International Conference and Expo on Parenterals & Injectables, will be organized around the theme “Exploring the Challenges in Parenterals and Injectables: Manufacturing and Sustainability”
Parenterals 2015 is comprised of 14 tracks and 79 sessions designed to offer comprehensive sessions that address current issues in Parenterals 2015.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Enhanced sterilization methods for pre-filled syringes
- Track 1-2Innovations with of pre-filled syringes systems
- Track 1-3Materials in the preparation of prefilled syringes
- Track 1-4Plastic or polymers used in pre-filled syringes
- Track 1-5Sterilization and validation protocol for pre-filled syringes
- Track 1-6Pre-filled syringes in market place
- Track 1-7Customization of pre-filled syringes to overcome its drawbacks and etc..
- Track 2-1Vaccines for parenteral use
- Track 2-2New parenteral vaccine approaches
- Track 2-3Parenteral vaccines Against Infectious Diseases and Cancers
- Track 2-4Parenteral norovirus vaccine formulations
- Track 2-5live parenteral vaccines
- Track 2-6Intravenous vaccines
- Track 2-7Risk assessment and management of parenteral vaccine usage etc..
- Track 3-1Infusions with syringe pumps
- Track 3-2Factors influencing the safety of device
- Track 3-3Modification of device features for enhanced patient comfort
- Track 3-4Quality Concerns and Considerations Injectable Products
- Track 3-5Analysis and safety evaluations of injectables and leachables and etc..
- Track 4-1New developments in delivery devices
- Track 4-2Improvements in micro liter dosing
- Track 4-3Aseptic transfer mechanisms
- Track 4-4Glass and plastic syringes-recent advances
- Track 4-5Injection site leakage-effect on drug dose etc..
- Track 5-1Wearable pre-filled syringes
- Track 5-2Drug injections into the eye
- Track 5-3New sterile packaging connection systems
- Track 5-4Novel needle technologies
- Track 5-5Advanced innovation for a new generation of needle free plastic pre-filled syringes
- Track 5-6Modern blow-fill-seal processing etc..
- Track 6-1Impact of silicone oil on delivery
- Track 6-2Overcoming variability in glass syringes
- Track 6-3Vapor phase polymers and its challenges etc..
- Track 7-1Generic sterile injectable drug-advances and drawbacks
- Track 7-2Route of administration
- Track 7-3Injections: a dangerous engine of disease
- Track 7-4Reported factors leading to injection overuse
- Track 7-5Misconceptions about injections among prescribers
- Track 7-6Factors influencing absorption and bioavailability of medications etc..
- Track 8-1Time to peak serum concentration by different modes of administration
- Track 8-2Sequential and prolonged parenteral antibiotics
- Track 8-3Pharmacokinetic advantages of parenteral over oral administration
- Track 8-4Therapeutic index and toxicity of Parenterals
- Track 8-5Clinical trials in parenterals and injectables etc..
- Track 9-1Market opportunities
- Track 9-2Market dynamics
- Track 9-3Meeting standards set by regulatory authorities
- Track 9-4Threat of substitutes
- Track 9-5Wider applications in parenterals etc..
- Track 10-1Developing and registering commercially successful injectable drug products
- Track 10-2Basic elements and requirements behind the regulation of Drug delivery combination products
- Track 10-3Risk Management for Temperature Controlled Distribution
- Track 10-4Regulatory issues about the standardization of pre-filled syringes
- Track 10-5Injectable and medical devices.
- Track 10-6Human factors and usability
- Track 10-7Clinical or Marketing Approval applications of parenteral
- Track 11-1In Situ Forming Parenteral Drug Delivery Systems
- Track 11-2lipid nanoparticles for injectable delivery
- Track 11-3Parenteral lipid nano dispersions
- Track 11-4Injectable liposomes etc..
- Track 12-1Clinical Guidelines for Parenteral Nutrition Compounding, Labeling, and Dispensing
- Track 12-2Parenteral Nutrition Safety Consensus Recommendations
- Track 12-3Safe Practices for Parenteral Nutrition Formulations
- Track 12-4Intravenous Admixture System
- Track 12-5Stability of parenteral admixtures
- Track 12-6Incompatibilities in parenteral admixtures etc..
- Track 13-1Formulation and Drug Delivery Strategies
- Track 13-2Advances & Progress in Drug Design
- Track 13-3Rational Drug Design
- Track 13-4In-silico Drug Design and in-silico screening
- Track 13-5Drug delivery case studies
- Track 13-6Clinical Pharmacology in Drug Development
- Track 13-7Development of sustained-release drug delivery systems etc..
- Track 14-1Drug Discovery in Preclinical Research
- Track 14-2Pharmacology in Drug Discovery
- Track 14-3Innovative Drug Discovery and Nanotechnology
- Track 14-4De-risking Drug discovery
- Track 14-5In silico approaches to fragment-based drug design
- Track 14-6Novel approaches in drug discovery